Hypoxia Imaging With FAZA-PET and Theoretical Considerations With Regard to Dose Painting for Individualization of Radiotherapy in Patients With Head and Neck Cancer
- 1 October 2007
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 69 (2) , 541-551
- https://doi.org/10.1016/j.ijrobp.2007.05.079
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Pretreatment 18F-FAZA PET Predicts Success of Hypoxia-Directed Radiochemotherapy Using TirapazamineJournal of Nuclear Medicine, 2007
- Prognostic Significance of [18F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02Journal of Clinical Oncology, 2006
- Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imagingMolecular Cancer Therapeutics, 2005
- Hypoxic cell turnover in different solid tumor linesInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II—clinical resultsInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Tumor microenvironmental physiology and its implications for radiation oncologySeminars in Radiation Oncology, 2004
- Hypoxia and Glucose Metabolism in Malignant TumorsClinical Cancer Research, 2004
- Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Imaging of hypoxia in human tumors with [F-18]fluoromisonidazoleInternational Journal of Radiation Oncology*Biology*Physics, 1992